Literature DB >> 32476823

Ventilatory disturbances in patients with intrathoracic sarcoidosis - a study from a functional and histological perspective.

Diana Calaras1, Oxana Munteanu1, Valentina Scaletchi2, I Simionica2, V Botnaru1.   

Abstract

Background: Although sarcoidosis is commonly considered a restrictive disorder, more recent studies demonstrated opposite results.
Objectives: To determine the prevalent functional pattern in patients with intrathoracic sarcoidosis and to assess the role of granulomatous inflammation in determining ventilatory disturbances.
Methods: We included 144 consecutive newly diagnosed patients with sarcoidosis, who were evaluated by chest radiography, chest high resolution computer tomography, pulmonary function tests and dyspnea score. Additionally, endobronchial and transbronchial biopsies were performed to a subset of 78 patients.
Results: We obtained a wide range of ventilatory abnormalities that characterize airways impairment: FEV1/FVC<70% - in 14 (9.7%) cases, low MMEF25-75 - in 69 (47.9%) patients, increased RV/TLC - in 65 (45.1%) subjects, while the subjects with restrictive defects was observed in a minority of cases - 7 (4.9%). Decreased DLCO was found in 100 (69.4%) individuals, in the majority of cases with mild changes. Patients in whom endobronchial biopsy showed granuloma had worse ventilatory results versus those in whom they have not been detected, with significant differences in FEV1 and MMEF25-75. We found significant correlations between radiological stage and pulmonary function tests. Dyspnea score (mMRC scale) in our cohort reflected lung volumes and DLCO modifications.
Conclusion: The dominant functional abnormality in patients with intrathoracic sarcoidosis is obstruction, which affects the entire length of the bronchial tree causing a wide range of airways impairment and altered gas diffusion. These functional disturbances are prevalent from early stages of the disease and have a tendency to coexist with restriction as the disease advances. Granulomatous inflammation seems to have an important role in determining obstructive defect, even from "infra-radiological" stages. (Sarcoidosis Vasc Diffuse Lung Dis 2017; 34: 58-67). Copyright:
© 2017.

Entities:  

Keywords:  obstruction; sarcoidosis; spirometry

Year:  2017        PMID: 32476823      PMCID: PMC7170114          DOI: 10.36141/svdld.v34i1.5134

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  27 in total

1.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

2.  Pulmonary hypertension in sarcoidosis.

Authors:  Robert P Baughman; Peter J Engel; Cris A Meyer; Amanda B Barrett; Elyse E Lower
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2006-06       Impact factor: 0.670

3.  Evaluation of clinical methods for rating dyspnea.

Authors:  D A Mahler; C K Wells
Journal:  Chest       Date:  1988-03       Impact factor: 9.410

4.  Airway obstruction in bronchial sarcoidosis: outcome with treatment.

Authors:  F Lavergne; C Clerici; D Sadoun; M Brauner; J P Battesti; D Valeyre
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

5.  Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis.

Authors:  P W Boros; P L Enright; P H Quanjer; G J J M Borsboom; S P Wesolowski; R E Hyatt
Journal:  Eur Respir J       Date:  2010-04-08       Impact factor: 16.671

Review 6.  Pulmonary sarcoidosis.

Authors:  J P Lynch; E A Kazerooni; S E Gay
Journal:  Clin Chest Med       Date:  1997-12       Impact factor: 2.878

7.  Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis.

Authors:  Tomohiro Handa; Sonoko Nagai; Yasutaka Fushimi; Shinji Miki; Kosuke Ohta; Akio Niimi; Michiaki Mishima; Takateru Izumi
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

8.  Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis.

Authors:  O P Sharma; R Johnson
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

9.  Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage.

Authors:  K Viskum; J Vestbo
Journal:  Eur Respir J       Date:  1993-03       Impact factor: 16.671

Review 10.  Sarcoidosis-associated pulmonary hypertension and lung transplantation for sarcoidosis.

Authors:  Michael Y Shino; Joseph P Lynch Iii; Michael C Fishbein; Charles McGraw; Jared Oyama; John A Belperio; Rajan Saggar
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

View more
  1 in total

1.  Impulse Oscillometry as a measure of airway dysfunction in Sarcoidosis.

Authors:  Geetanjali Bade; Nasim Akhtar; Anjali Trivedi; Karan Madan; Randeep Guleria; Anjana Talwar
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-09-30       Impact factor: 0.670

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.